The 11 patients were admitted to the hospital on 20, 21, and 22 January. "Now that their condition has improved and they are clinically stable, we are planning to taper the doses of Atropine under ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...